Items where Author is "Prósper, F"

Up a level
Export as [feed] RSS
Group by: Item Type | No Grouping
Number of items: 5.

MONTIEL-DUARTE, C., CORDEU, L., AGIRRE, X., ROMÁN-GÓMEZ, J., JIMÉNEZ-VELASCO, A., SAN, J.E., GÁRATE, L., ANDREU, E.J., CALASANZ, M.J., HEINIGER, A., TORRES, A. and PRÓSPER, F., 2008. Resistance to Imatinib Mesylate-induced apoptosis in acute lymphoblastic leukemia is associated with PTEN down-regulation due to promoter hypermethylation. Leukaemia Research, 32 (5), pp. 709-716. ISSN 0145-2126

AGIRRE, X., ROMAN-GOMEZ, J., JIMENEZ-VELASCO, A., GARATE, L., MONTIEL-DUARTE, C., NAVARRO, G., VÁZQUEZ, I., ZALACAIN, M., CALASANZ, M.J., HEINIGER, A., TORRES, A., MINNA, J.D. and PRÓSPER, F., 2006. ASPP1, a common activator of TP53, is inactivated by aberrant methylation of its promoter in acute lymphoblastic leukemia. Oncogene, 25 (13), pp. 1862-1870. ISSN 0950-9232

ANDREU, E.J., LLEDÓ, E., POCH, E., IVORRA, C., ALBERO, M.P., MARTÍNEZ-CLIMENT, J.A., MONTIEL-DUARTE, C., RIFÓN, J., PÉREZ-CALVO, J., ARBONA, C., PRÓSPER, F. and PÉREZ-ROGER, I., 2005. BCR-ABL induces the expression of Skp2 through the PI3K pathway to promote p27 Kip1 degradation and proliferation of chronic myelogenous leukemia cells. Cancer Research, 65 (8), pp. 3264-3272. ISSN 0008-5472

AGIRRE, X., FONTALBA, A., ANDREU, E.J., ODERO, M.D., LARRÁYOZ, M.J., MONTIEL, C., CALASANZ, M.J., FERNÁNDEZ-LUNA, J.L. and PRÓSPER, F., 2003. Lack of Bcr-Abl point mutations in chronic myeloid leukemia patients in chronic phase before imatinib treatment is not predictive of response. Haematologica, 88 (12), pp. 1425-1426. ISSN 0390-6078

AGIRRE, X., FONTALBA, A., ANDREU, E.J., ODERO, M.D., LARRÁYOZ, M.J., MONTIEL, C., CALASANZ, M.J., FERNÁNDEZ-LUNA, J.L. and PRÓSPER, F., 2003. Lack of Bcr-Abl point mutations in chronic myeloid leukemia patients in chronic phase before imatinib treatment is not predictive of response. Haematologica, 88 (12), pp. 1425-1426. ISSN 0390-6078

This list was generated on Fri Mar 29 05:49:40 2024 UTC.